Evidence map›Paper›PMID 35795184›Full record

ArticleFrontiers in cellular and infection microbiology2022

CT295 Is

Sébastien Triboulet, Maimouna D N'Gadjaga, Béatrice Niragire, Stephan Köstlbacher, Matthias Horn, Vishukumar Aimanianda, Agathe Subtil

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sébastien TribouletInstitut Pasteur, Université Paris Cité, CNRS UMR3691, Unité de Biologie Cellulaire de l'Infection Microbienne, Paris, France.
Maimouna D N'GadjagaInstitut Pasteur, Université Paris Cité, CNRS UMR3691, Unité de Biologie Cellulaire de l'Infection Microbienne, Paris, France.
Béatrice NiragireInstitut Pasteur, Université Paris Cité, CNRS UMR3691, Unité de Biologie Cellulaire de l'Infection Microbienne, Paris, France.
Stephan KöstlbacherCentre for Microbiology and Centre for Microbiology and Environmental Systems Science, University of Vienna, Vienna, Austria.
Matthias HornCentre for Microbiology and Centre for Microbiology and Environmental Systems Science, University of Vienna, Vienna, Austria.
Vishukumar AimaniandaInstitut Pasteur, Université Paris Cité, CNRS UMR2000, Unité de Mycologie Moléculaire, Paris, France.
Agathe SubtilInstitut Pasteur, Université Paris Cité, CNRS UMR3691, Unité de Biologie Cellulaire de l'Infection Microbienne, Paris, France.
Centre National de la Recherche Scientifique · FRUniversité Paris Cité · FRUniversity of Vienna · ATInstitut Pasteur · FR

Funding

Austrian Science Fund FWF DOC 69
6 · The paper itself

Abstract

The obligate intracellular bacteria

Indexed as

Chlamydia trachomatisPhosphoglucomutaseGlucose-6-PhosphateGlycogenVacuolesGlucose-6-PhosphateGlycogenPhosphoglucomutaseChlamydiaglycogen, metabolismphosphoglucomutase (PGM)secretion signaltype 3 secreted effectors

Identifiers

PMID35795184
PMCPMC9251005
OpenAlexW4283162475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.